Posted on December 10, 2008 11:47
Topics: Expenditures | Medicaid | Medicare | Mental Health | Prescription Drugs
Post Type: citation
This article analyzes the complexity surrounding Medicare drug plan choices for individuals requiring psychotropic drugs and the implications for policymakers and patients.
Zivin, K., McCammon, R. J., Davis, M. M., Halasyamani, L. K., & Kales, H. C. (2008). Increases in Medicare prescription drug plan costs attributable to psychotropic medications. American Journal of Geriatric Psychiatry, 16(8), 674-85. http://ajgponline.org/cgi/content/abstract/16/8/674
Authors: Kara Zivin, Ryan J. McCammon, Matthew M. Davis, Lakshmi K. Halasyamani, Helen C. Kales.
E-mail to Friend |
Print |
Permalink |
|
Post RSS
